Skip to the page

Data / Drug companies / Grandall Distributing, LLC

Grandall Distributing, LLC: 9 products in the FDA NDC directory, labeler code 48201

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Grandall Distributing, LLC (labeler code 48201) lists 9 products in the FDA National Drug Code Directory, covering 7 finished drugs by generic name. By type: 9 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on December 18, 2024.

The request: Watch Grandall Distributing, LLC (FDA labeler code 48201): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
48201
Products in commercial distribution
9
Packages
10
Finished drugs by generic name
7
Prescription products
0
Over the counter products
9
Flagged as original packager
9 of 9 products that carry the flag
Started marketing in the last 12 months
0
Earliest marketing start
March 31, 2015
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs888.9%
Generic drugs (ANDA)111.1%

Products by type

TypeProductsShare
Over the counter drugs9100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Solution/ drops222.2%
Ointment222.2%
Tablet111.1%
Shampoo111.1%
Liniment111.1%
Powder111.1%
Capsule, gelatin coated111.1%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Oftal-mycin lubricant ophthalmic48201-301OintmentOver the counter monograph drugsDecember 18, 2024
Polvo de sulfa first aid antibiotic48201-105PowderOver the counter monograph drugsJuly 18, 2024
Pomada sulfa first aid antibiotic48201-104OintmentOver the counter monograph drugsJuly 18, 2024
Colirio Oftal-Mycin48201-107Solution/ dropsOver the counter monograph drugsJanuary 1, 2024
Colirio Ojo De Aguila Eye Drops48201-106Solution/ dropsOver the counter monograph drugsJanuary 1, 2024
Mata Piojos Lice48201-006ShampooOver the counter monograph drugsJuly 9, 2015
Calmadol48201-004LinimentOver the counter monograph drugsJuly 8, 2015
Sanaflu Xtra48201-001Capsule, gelatin coatedOver the counter monograph drugsApril 30, 2015
Calmadol pain reliever48201-007TabletGeneric drugs (ANDA)March 31, 2015

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.